相关实验视频

Updated: Jul 11, 2025

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

一个由免疫检查点抑制剂诱导的布鲁加达表样变化的病例

Jianming Zhang¹, Huayong Jin¹

¹Department of Electrocardiology, Shaoxing People's Hospital, Shaoxing, China.

Journal of electrocardiology

|November 4, 2023

概括

免疫检查点抑制剂可能会导致心脏问题. 这份病例报告强调了布鲁加达表现物可能由这些药物诱导,即使没有典型的心脏酶变化.

科学领域:

心脏病学心脏病学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

免疫检查点抑制剂 (ICI) 通过增强T细胞监测,彻底改变了癌症治疗.
然而,ICI可以引发严重的免疫相关不良事件 (irAEs).
心脏激发性心脏病,特别是免疫媒介性心肌炎是一个重大问题.

关键词:

布鲁加达的副本案例报告案例报告电心电图 (ECG) 是一种心电图.免疫检查点抑制剂免疫检查点抑制剂

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...